Published: March 20, 2026 · Updated: March 2026

Hair Relaxer Cancer Lawsuit 2026: MDL 3060 Status and Latest Developments

Last updated: March 2026

The hair relaxer cancer lawsuit is one of the most significant mass tort cases in the United States right now. More than 11,000 women — most of them Black — have filed claims against companies like L'Oréal, Revlon, Namaste Laboratories, and Strength of Nature. They say these companies sold chemical hair straighteners containing toxic ingredients that caused uterine cancer, ovarian cancer, and other reproductive harm. And they're saying the companies knew.

If you used chemical hair relaxers and have been diagnosed with a serious illness, here's where things stand and what it means for you.

What Is the Hair Relaxer Cancer Lawsuit?

The hair relaxer cancer lawsuit is a federal multidistrict litigation (MDL) — case number MDL 3060 — consolidated in the Northern District of Illinois before Judge Mary Rowland. Thousands of individual lawsuits were combined into this single proceeding to make the litigation more efficient.

Plaintiffs claim that chemical hair relaxers contain endocrine-disrupting chemicals (EDCs) such as phthalates, parabens, bisphenol-A, and cyclosiloxanes. These chemicals mimic estrogen in the body and have been linked to hormone-sensitive cancers of the reproductive system.

The lawsuit also claims that manufacturers knew — or should have known — about these risks for years and failed to warn consumers.

What Started This Lawsuit?

The lawsuits started after a landmark NIH study published in October 2022. Researchers followed nearly 34,000 women for over a decade and found that women who used chemical hair straighteners more than four times a year had a 2.55 times greater risk of developing uterine cancer compared to women who never used them.

This was one of the largest epidemiological studies on this question ever conducted. It came from one of the most respected research institutions in the world. Published in the Journal of the National Cancer Institute.

Before that study, most women had no reason to connect their cancer to the products they'd been using since childhood. After it came out, the connection became hard to dismiss.

Who Are the Defendants?

The companies named most frequently in MDL 3060 include:

• L'Oréal USA — parent company of Dark & Lovely, Soft Sheen Carson, and other brands heavily marketed to Black women
• Revlon — maker of Realistic, Creme of Nature, and other relaxer lines
• Namaste Laboratories — maker of ORS Olive Oil and other natural-marketing products that still contained synthetic chemicals
• Strength of Nature — maker of Motions, TCB Naturals, and others
• Godrej SON Holdings — various subsidiary brands

Plaintiffs allege these companies targeted Black women with aggressive marketing while concealing the health risks associated with the chemicals in their products.

What Are the Latest Developments in 2026?

Punitive Damages Approved

In September 2024, Judge Rowland ruled that plaintiffs can seek punitive damages from the defendant manufacturers. This is a major development. Punitive damages go beyond compensating the injured person — they punish companies for particularly reckless or deceptive behavior. The approval of punitive damages significantly raises the financial stakes for manufacturers and gives them stronger motivation to settle cases.

Bellwether Case Discovery

The 32 bellwether cases are in intensive discovery. This process involves exchanging documents (including internal company records and scientific studies), taking depositions of corporate executives and scientists, and developing expert witnesses on both sides. The outcomes of bellwether trials guide how the rest of the MDL resolves — they act as test cases for the broader litigation.

Daubert Hearings on the Horizon

The critical upcoming milestone is the Daubert hearing, scheduled for mid-2026. At these hearings, Judge Rowland will decide whether expert witnesses can testify at trial that chemical hair relaxers cause the cancers and conditions alleged. If the scientific experts are allowed to testify, it substantially strengthens the plaintiff position for all 11,000+ cases. If not, cases would face serious hurdles.

Legal observers expect the court to allow the testimony based on the existing scientific record, but the ruling is not guaranteed.

No Settlement Yet — But Pressure Is Building

As of March 2026, there is no global settlement. However, the approval of punitive damages, the scale of the litigation, and the upcoming trial deadlines are all creating pressure on defendants. Settlement talks are believed to be ongoing in the background. When a settlement is announced, it typically comes quickly and unexpectedly.

Who Qualifies to File a Claim?

You may qualify for the hair relaxer cancer lawsuit if:

• You used chemical hair relaxers or straighteners regularly (typically 4+ times per year) for at least one year
• You have been diagnosed with uterine (endometrial) cancer, ovarian cancer, uterine fibroids, or endometriosis
• Your diagnosis came after at least one year of regular hair relaxer use
• You are within the statute of limitations for your state (typically 2–3 years from diagnosis)

The earlier you used these products, the better your potential claim. Many women started using relaxers as children, which means years or even decades of chemical exposure.

See if you qualify for the hair relaxer cancer lawsuit →

Should You File a Claim Now?

If you think you qualify, there are good reasons not to wait:

• Statutes of limitations are running. Some states give you as little as 1–2 years from the date you knew or should have known about the connection between your illness and hair relaxers.
• Evidence degrades. Medical records become harder to locate. Witnesses' memories fade. Products may no longer be traceable.
• Earlier claimants often fare better. In many mass tort settlement structures, early filers receive priority consideration.
• A settlement could close new claims. Once a global settlement is announced, there is typically a limited window to opt in. Women who have not already filed may be excluded.

Filing a claim does not cost anything upfront. Mass tort attorneys work on contingency — they only get paid if you receive compensation.

What Can You Recover?

Compensation in hair relaxer cancer cases may include:

• Medical expenses (past and future cancer treatment, surgery, chemotherapy, radiation)
• Lost income and reduced earning capacity
• Pain and suffering
• Emotional distress
• Loss of quality of life
• In some cases, loss of fertility or reproductive capacity
• Punitive damages (now approved by the court)

While no settlement has been announced, legal experts estimate individual settlement values in the range of $100,000 to over $1 million depending on the severity of the cancer, treatment required, and individual circumstances. Women with aggressive cancers requiring major surgery or chemotherapy are likely to receive higher compensation.

Sources

• Chang CJ et al. "Hair product use and incident uterine cancer." JNCI, October 2022.
• In re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation, MDL No. 3060 (N.D. Ill.)
• NIH National Institute of Environmental Health Sciences, Sister Study